Elliott Griffin
Director @ Business Venture Partners
Elliott Griffin is a seed investor at Business Venture Partners focused on Health Care and Medical. Elliott is the founder and managing director of BVP. He attended University College Dublin.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 78%
Last updated:
For AI agents: llms.txt
Industries Elliott Griffin invests in
Stages Elliott Griffin invests in
Countries Elliott Griffin invests in
Investment Focus
Industry
- Health Care 6 (67%)
- Medical 2 (22%)
- Software 2 (22%)
- Medical Device 2 (22%)
- SaaS 1 (11%)
Stage
- Seed 4 (44%)
- Funding Round 2 (22%)
- Series A 1 (11%)
- Venture - Series Unknown 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Oranda Therapeutics focuses on developing and commercializing innovative medicines to improve the lives of patients. | Seed / Mar 01, 2026 | |
|
|
Novus Diagnostics are developing a revolutionary sample-to-answer sepsis diagnostic device that can rapidly detect and classify pathogens in whole blood. | $4.7M / Seed / Jan 15, 2025 | |
|
|
X-BOLT Orthopaedics developed a novel expanding bolt device, with associated implants and instrumentation systems, for internal bone fixation in osteoporotic hip fractures. X-BOLT hip plating and nailing systems allow surgeons choice to treat all morphologies of proximal femoral fractures. | $3.5M / Venture - Series Unknown / Oct 29, 2023 | |
|
|
Wellola connects clinics & their own clients, anywhere, anytime. It is designed for the forward-thinking healthcare professional. Our cloud-based platform offers secure video-consultation software combined with simple payment/practice management facilities. | $1.1M / Seed / May 23, 2022 | |
|
|
p3- people, programming and processes- a great combination that can drive more bookings for your hotels. Fully integrated with OWS (Opera web services) and hosted on a secure PCI DSS platform, our technology is ideally suited for hotel groups. We are already helping international hotel groups grow their online revenue. But don’t take our word forit. Take a look at our client success stories at www.p3hotels.com - The results speak for themselves! | $820.7K / Mar 14, 2022 | |
|
|
HealthBeacon is a connected health care device designed to drive treatment adherence for patients on self-injectable medications. It observes patient compliance, identifies patient behavior, and subsequently engages the patient to achieve higher medication adherence for patients on home injectable medication.HealthBeacon also alerts patientswhen they need to take their medication and sends them a text when they forget. | $5.8M / Nov 24, 2020 | |
|
|
Almost 1 billion people are faced with highly disruptive digestive symptoms. These symptoms are often severe, persistent, and can have a profound impact on daily life. It has developed a connected device called AIRE to help people with these issues, gain back control of their digestion, and by extension, their lives. Working as a personal breathanalyzer, AIRE can achieve this by helping the user find the foods that are most compatible with their unique digestive system. Based on an existing clinical test, AIRE enables you to craft a personalized diet, so you can be at your very best. We have taken over $500,000 of pre-orders so far on foodmarble.com and once we start shipping out devices in late 2017, they will start building the first data-set of its kind. | $2.2M / Seed / Oct 20, 2020 | |
|
|
HealthBeacon is a connected health care device designed to drive treatment adherence for patients on self-injectable medications. It observes patient compliance, identifies patient behavior, and subsequently engages the patient to achieve higher medication adherence for patients on home injectable medication.HealthBeacon also alerts patientswhen they need to take their medication and sends them a text when they forget. | $12M / Series A / Jan 08, 2019 | |
|
|
HealthBeacon is a connected health care device designed to drive treatment adherence for patients on self-injectable medications. It observes patient compliance, identifies patient behavior, and subsequently engages the patient to achieve higher medication adherence for patients on home injectable medication.HealthBeacon also alerts patientswhen they need to take their medication and sends them a text when they forget. | $1.1M |
Co-Investors
About Business Venture Partners
Business Venture Partners was founded in 2004 as a corporate finance adviser for SME/owner managed businesses. The investment team is comprised of Elliott Griffin, Ronan Smith, Edel Coen and Mark Ruane and the team skills combine deep industry knowledge with experience in venture investing, corporate finance and international expansion. Theteam works on behalf of its clients buying and selling companies, raising finances, working with start-ups and advising on strategic growth, business succession and owner exits.Since 2007, BVP has successfully raised and managed 10 Simple Green BES and EII Funds. They have invested, on behalf of their investors, in some of Ireland’s most innovative companies such as Celtic Bioenergy, EFT Controls, and UrbanVolt. Our investment strategy is to spread investments over project finance and a portfolio of high potential companies. Their philosophy is to work hard with each investment to deliver valuable support for the company promoters and build shareholder value for their investors.In 2016 BVP launched The 10th BVP Green EII Fund. The fund provides eligible investors with the opportunity to avail of up to 40% income tax relief and provides the investor access to a portfolio of cleantech companies and renewable energy projects. The 11th Green Fund will be launched in Q4 2017.
Business Venture Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Elliott Griffin
Director
|
|||
|
Edel Coen
Investment Executive
|
|||
|
Mark Ruane
Finance and Investment Associate
|
|||
|
Ronan Smith
Investment Executive
|
|||
|
Stephen Burdock
Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Elliott Griffin invest in?
Elliott Griffin invests primarily in Health Care, Medical and Software startups, most often at Seed and Funding Round stage. Most of the 9 investments tracked by Shizune back companies in Ireland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Elliott Griffin last invest?
The most recent investment recorded for Elliott Griffin closed in Mar 2026. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!